RPID — Rapid Micro Biosystems Balance Sheet
0.000.00%
Last trade - 00:00
- $29.78m
- -$49.46m
- $22.52m
- 25
- 61
- 26
- 30
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 12.5 | 45.1 | 193 | 109 | 92.1 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4.92 | 5.78 | 5.63 | 5.48 | 5.58 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 23.6 | 62.1 | 218 | 139 | 120 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7.59 | 7.05 | 11.3 | 20.9 | 19.1 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 31.7 | 70 | 241 | 191 | 143 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10.5 | 15.5 | 18.2 | 19.1 | 19 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 32.4 | 45.2 | 20.2 | 26.5 | 25.5 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Total Equity | -0.725 | 24.8 | 221 | 164 | 118 |
Total Liabilities & Shareholders' Equity | 31.7 | 70 | 241 | 191 | 143 |
Total Common Shares Outstanding |